Aditxt, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ADTX, updated each market day.
ADTX AI Sentiment
AI predicts Aditxt, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Aditxt, Inc. Common Stock
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues. The company operates in one segment, which is focused on the discovery and development of biopharmaceutical products.
Sector
Exchange
Market Cap
$479,368
Cap Tier
Employees
26
Headquarters
RICHMOND, VA
Listed Since
June 30, 2020
Website
ADTX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ADTX Volatility
Aditxt, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
